From the Department of Cell Biology and Physiology (C.-J.L., B.M.H., R.A.R., R.P.M.).
Department of Internal Medicine, Cardiovascular Division (C.-J.L.).
Circ Res. 2019 Nov 8;125(11):1006-1018. doi: 10.1161/CIRCRESAHA.119.315348. Epub 2019 Oct 8.
Elastin is an important ECM (extracellular matrix) protein in large and small arteries. Vascular smooth muscle cells (SMCs) produce the layered elastic laminae found in elastic arteries but synthesize little elastin in muscular arteries. However, muscular arteries have a well-defined internal elastic lamina (IEL) that separates endothelial cells (ECs) from SMCs. The extent to which ECs contribute elastin to the IEL is unknown.
To use targeted elastin (Eln) deletion in mice to explore the relative contributions of SMCs and ECs to elastic laminae formation in different arteries.
We used SMC- and EC-specific recombinase transgenes with a novel floxed allele to focus gene inactivation in mice. Inactivation of in SMCs using resulted in depletion of elastic laminae in the arterial wall with the exception of the IEL and SMC clusters in the outer media near the adventitia. Inactivation of elastin in ECs using or resulted in normal medial elastin and a typical IEL in elastic arteries. In contrast, the IEL was absent or severely disrupted in muscular arteries. Interruptions in the IEL resulted in neointimal formation in the ascending aorta but not in muscular arteries.
Combined with lineage-specific fate mapping systems, our knockout results document an unexpected heterogeneity in vascular cells that produce the elastic laminae. SMCs and ECs can independently form an IEL in most elastic arteries, whereas ECs are the major source of elastin for the IEL in muscular and resistance arteries. Neointimal formation at IEL disruptions in the ascending aorta confirms that the IEL is a critical physical barrier between SMCs and ECs in the large elastic arteries. Our studies provide new information about how SMCs and ECs contribute elastin to the arterial wall and how local elastic laminae defects may contribute to cardiovascular disease.
弹性蛋白是大、小动脉中重要的细胞外基质(ECM)蛋白。血管平滑肌细胞(VSMC)产生弹性动脉中发现的分层弹性层,但在肌性动脉中合成的弹性蛋白很少。然而,肌性动脉有一个明确的内弹性膜(IEL),将内皮细胞(EC)与血管平滑肌细胞分开。EC 向 IEL 贡献弹性蛋白的程度尚不清楚。
利用靶向弹性蛋白(Eln)缺失的小鼠,探讨 SMC 和 EC 对不同动脉弹性层形成的相对贡献。
我们使用了带有新型 floxed 等位基因的 SMC 和 EC 特异性重组酶转基因,以在小鼠中聚焦基因失活。使用 对 SMC 中的 进行失活导致除了 IEL 和外膜中靠近外膜的 SMC 簇之外,动脉壁中的弹性层消失。使用 或 对 EC 中的弹性蛋白进行失活导致弹性动脉中的中膜弹性蛋白正常和典型的 IEL。相比之下,IEL 在肌性动脉中不存在或严重受损。IEL 的中断导致升主动脉中的新生内膜形成,但不在肌性动脉中。
结合谱系特异性命运映射系统,我们的敲除结果证明了血管细胞产生弹性层的意外异质性。SMC 和 EC 可以独立在大多数弹性动脉中形成 IEL,而 EC 是肌性和阻力动脉中 IEL 弹性蛋白的主要来源。在升主动脉中 IEL 中断时的新生内膜形成证实了 IEL 是大弹性动脉中 SMC 和 EC 之间的重要物理屏障。我们的研究提供了关于 SMC 和 EC 如何向动脉壁贡献弹性蛋白以及局部弹性层缺陷如何导致心血管疾病的新信息。